Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome

NCT05330845 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Stopped end of recruitment period

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL: IL6 assessment
BIOLOGICAL: CRP and PCT assessment

Sponsor

Centre Hospitalier Henri Duffaut - Avignon